Aseptic Pharma Processing Market: Current Analysis and Forecast (2021-2027)

Aseptic Pharma Processing Market: Current Analysis and Forecast (2021-2027)

Global Aseptic Pharma Processing Market is anticipated to grow with an elevated CAGR of around 8% over the forecast period (2021-2027). Aseptic Pharma Processing is the processing of various pharmaceutical products including drug components, drug product containers, and excipients in a manner that prevents any microbial contamination of the final sealed product.

The global aseptic pharma processing market is anticipated to witness an uptick owing to the increase in expenditure on pharmaceutical R&D across the globe. For instance, In 2019, research and development spending in the pharmaceutical industry was USD 186 billion globally. In comparison, the R&D expenditures totaled USD 159 billion in 2016. Further, this spending is anticipated to reach USD 233 billion by 2026. Owing to this, there has been an increase in the number of drug launches and drug approvals over the last few years. In addition to this, the advancement in the pharma and medical field, the flourishing biotechnology industry, and the safety concerns regarding biological medicinal products are some factors driving the growth of the market globally.

Furthermore, the aseptic pharma processing market is anticipated to grow on account of the growing technological advancement, many ongoing research activities in this field, rising government and public-private investments, and various benefits associated with the aseptic processing. Some of the benefits include increased shelf life, eco-friendliness, and maintaining the quality of content. Additionally, the adoption of robotic solutions in the pharmaceutical industry is due to its cost-effectiveness and faster performance for aseptic processes to meet the growing demand for pharmaceuticals. However, some of the restraints in the market including high initial capital investment and lack of skilled professionals in emerging economies are some factors impeding the growth of this market all over the world.

Abbvie Inc., Lonza Group, Baxter International Inc., Robert Bosch GmbH, Alcami Corporation, Amcor Plc, Becton, Dickinson & Co, Samsung Biologics, Symbiosis Pharmaceutical Services, Recro Pharma, are some of the prominent players operating in the aseptic pharma processing market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with aseptic pharma processing.

Insights Presented in the Report

“Amongst Component, processing equipment segment holds the major share”

Based on components, the aseptic pharma processing market is segmented into processing equipment and packaging equipment. The processing equipment segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to the growing demand for the prolonged shelf life and aseptic processing of the pharmaceuticals. However, the packaging equipment is also anticipated to grow in the upcoming years due to the surging demand for eco-friendly and hygienic packaging for pharmaceutical products.

“Amongst Technology, lyophilization segment holds the major share”

Based on technology, the market is fragmented into drying, lyophilization, closed vial technology, blow fill seal technology, and others. In 2020, the lyophilization segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period on the account of its assurance to keep an aseptic environment for the pharmaceutical product. However, the blow-fill-seal technology segment is also likely to witness considerable growth during the forecast period as this technology is extensively used in liquid pharmaceutical applications and is gradually proliferating into biologics.

“Amongst Application, ophthalmic suspensions segment holds the major share”

Based on application, the aseptic pharma processing market is segmented into ophthalmic suspensions, reconstituted lyophilized powders for injection, sterile injectables, aqueous-based aerosols for inhalation, and others. The ophthalmic suspension segment occupied the major share of the aseptic pharma processing market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years. The growth of this segment is attributed to the growing demand for ophthalmic suspensions owing to the rising prevalence of eye-related disorders. Furthermore, the need to sterilize these products owing to the high chances of microbial content or the bio-burden of the raw materials is also one of the prominent factors driving the growth of this segment.

“North America represents one of the largest markets of Aseptic Pharma Processing market”

For a better understanding of the market dynamics of the aseptic pharma processing market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the aseptic pharma processing market industry and generated revenue of USD XX Million in 2020 owing to strong healthcare infrastructure and growing demand for pharmaceutical supplies in the region.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry